Stifel Financial Corp Ginkgo Bioworks Holdings, Inc. Transaction History

Stifel Financial Corp

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	SELL	$0.28 - $1.16 $35,150 - $145,621	-125,536 Reduced 55.7%	99,840 $32,000
Q1 2024 May 13, 2024	BUY	$1.06 - $1.67 $70,390 - $110,898	66,406 Added 41.77%	225,376 $261,000
Q4 2023 Feb 12, 2024	BUY	$1.26 - $1.79 $15,203 - $21,598	12,066 Added 8.21%	158,970 $268,000
Q3 2023 Nov 13, 2023	BUY	$1.61 - $2.54 $46,617 - $73,545	28,955 Added 24.55%	146,904 $265,000
Q2 2023 Aug 14, 2023	BUY	$1.14 - $1.95 $21,340 - $36,504	18,720 Added 18.87%	117,949 $219,000
Q1 2023 May 12, 2023	BUY	$1.2 - $2.19 $19,623 - $35,813	16,353 Added 19.73%	99,229 $131,000
Q4 2022 Feb 13, 2023	BUY	$1.63 - $3.52 $23,423 - $50,582	14,370 Added 20.98%	82,876 $140,000
Q3 2022 Nov 14, 2022	BUY	$0.73 - $3.74 $6,361 - $32,594	8,715 Added 14.58%	68,506 $214,000
Q2 2022 Aug 15, 2022	BUY	$2.2 - $4.2 $43,018 - $82,126	19,554 Added 48.6%	59,791 $142,000
Q1 2022 May 13, 2022	BUY	$2.83 - $8.69 $113,870 - $349,659	40,237 New	40,237 $162,000

48.1M

Ticker DNA
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 1,287,779,968
Market Cap $13.2B
Description
Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops platform for cell programming. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum. The company serves various end markets, including specialty chemicals, agric...

Get notified when there are updates to the investment portfolio of Stifel Financial Corp, based on Form 13F filings with the SEC.

Stay updated on Stifel Financial Corp with notifications on news.